Dr. Allen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13532 Steelecroft Pkwy
Charlotte, NC 28278Phone+1 704-295-3475Fax+1 704-295-3476
Education & Training
Ohio State University HospitalResidency, Ophthalmology, 2012 - 2015
University of Tennessee College of Medicine at ChattanoogaInternship, Transitional Year, 2011 - 2012
Medical College of Georgia at Augusta UniversityClass of 2011
Certifications & Licensure
NC State Medical License 2017 - 2025
OH State Medical License 2012 - 2017- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 29 citationsAflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.Chirag D Jhaveri, Adam R Glassman, Frederick L Ferris 3rd, Danni Liu, Maureen G Maguire
The New England Journal of Medicine. 2022-08-25 - 5 citationsEffects of incision location on specimen quality and complications for temporal artery biopsy.Craig N. Czyz, John B Allen, Kenneth V. Cahill, Cameron Nabavi, Jill A. Foster
Vascular. 2019-08-01 - 3 citationsMIF promoter polymorphisms are associated with epiretinal membrane but not retinal detachment with PVR in an american population.Colleen M. Cebulla, William Stevenson, Heather Van Law, Tyler Heisler-Taylor, Sumaya Hamadmad
Experimental Eye Research. 2019-05-17
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
